2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3013
  



  

  
Submitter : 
  

  
Mrs. Jamie Adams
  

  
Date & Time: 
  

  
12/12/2006 09:12:10
  



  

  
Organization : 
  

  
Mrs. Jamie Adams
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 This letter is in response to the FDA invitation for public comment on the Industry Guidelines for development of cell-based viral vaccines.  I would like to comment on the use of human diploid cell lines, MRC-5, WI-38, HEK-293, IMR-90, PER C6 and any other cell substrates that may arise in the future which are derived from electively aborted fetuses.



I and my family are in strong opposition to the use of cells from aborted fetuses and as a result have elected to postpone indefinitely the use of any vaccines that are derived from such sources, in hopes that morally-sound vaccines will be developed.



We encourage you to support alternative sources of cells that are not morally compromised in the development of new and existing vaccines, so that we can select vaccinations that do not violate our moral principles.



Sincerely,



Mrs. Jamie Adams